1. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (6096)
  2. Meeting Abstract (6017)
  3. Review (387)
  4. Book Section (215)
  5. Editorial (164)
  6. Research Letter (151)
  7. Guidelines (80)
  8. Conference Paper (70)
  9. Correspondence (56)
  10. Miscellaneous (17)
  11. Book Whole (10)
Groups
  1. Center for Hematologic Malignancies (13263)
  2. Department of Medicine (10841)
  3. Hematologic Malignancies, Division of (10394)
  4. GSK Faculty (5359)
  5. Adult Leukemia (3617)
  6. Sloan Kettering Institute Faculty (3339)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (158)
  2. 2024 (575)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3280)
  2. Journal of Clinical Oncology (860)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (303)
  5. Cancer Research (300)
  6. Haematologica (266)

More Publications

Publishers
  1. American Society of Hematology (3541)
  2. Elsevier Inc. (1674)
  3. Nature Publishing Group (1091)
  4. American Society of Clinical Oncology (905)
  5. American Association for Cancer Research (670)
  6. Wiley Blackwell (432)

More Publishers

Results (13263)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lexatumumab: Results of phase I trial in pediatric patients with advanced solid tumors
    Meeting Abstract

    Merchant, M. S.; Chou, A. J.; Price, A.; Geller, J. I.; Tsokos, M.; Graham, C.; Charles, A.; Meyers, P. A.; Mackall, C.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Prevalence of hepatitis B surface antigen and hepatitis B core antibody in a population initiating immunosuppressive therapy
    Meeting Abstract

    Ludwig, E.; Mendelsohn, R. B.; Taur, Y.; Kamboj, M.; Nagula, S.; Sepkowitz, K.; Zelenetz, A. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Duodenal follicular lymphoma: Clinical and pathologic characteristics, management, and outcomes
    Meeting Abstract

    Jhaveri, A. P.; Maragulia, J.; Zelenetz, A. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II study of bortezomib with ifosfamide and vinorelbine in pediatric patients with refractory/recurrent Hodgkin disease (HD): A Children's Oncology group (COG) study
    Meeting Abstract

    Horton, T. M.; Drachtman, R. A.; Chen, L.; Trippett, T. M.; De Alarcon, P.; Chen, A. R.; Guillerman, R. P.; McCarten, K.; Hogan, S. M.; Schwartz, C. L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A multicenter, first-in-pediatrics phase I study of ridaforolimus (AP23573, MK-8669) in patients (pts) with refractory solid tumors
    Meeting Abstract

    Gore, L.; Trippett, T. M.; Katzenstein, H. M.; Boklan, J. L.; Narendaren, A.; Smith, A.; Macy, M.; Narasimhan, N.; Turner, C. D.; Nieder, M. L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL)
    Meeting Abstract

    Flowers, C.; Taylor, M.; Hirata, J.; Dillon, H.; Zelenetz, A. D.; Hainsworth, J. D.; Cerhan, J. R.; Rogers, E. S.; Friedberg, J. W.; Link, B. K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A single-institution (MSKCC) analysis of incidence and clinical outcomes in patients with thromboembolic events and exocrine pancreas cancer
    Meeting Abstract

    Epstein, A. S.; Crosbie, C.; Gardos, S.; Soff, G. A.; Shah, M. A.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Hypogammaglobulinemia in pts receiving rituximab immunotherapy and the impact of rituximab maintenance
    Meeting Abstract

    Casulo, C.; Maragulia, J.; Zelenetz, A. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I study of single-agent perifosine for recurrent pediatric solid tumors
    Meeting Abstract

    Becher, O. J.; Trippett, T. M.; Kolesar, J.; Gilheeney, S.; Jiang, Z.; Khakoo, Y.; Lyden, D.; Sima, C.; Holland, E. C.; Dunkel, I. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer (CRPC) treated with MDV3100
    Meeting Abstract

    Anand, A.; Scher, H. I.; Beer, T. M.; Higano, C. E.; Danila, D. C.; Taplin, M.; Efstathiou, E.; Hirmand, M.; Sawyers, C. L.; Heller, G.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save